SORT BY

FILTER BY

also on other fortune lists

company facts

f500 stats

Fortune 500

Courtesy of Zimmer Biomet Holdings

352

Zimmer Biomet Holdings

ZBH

The medical device company sprung from the $14 billion mega merger between two orthopedic powerhouses, Zimmer and Biomet, in 2015. Since then, the company has seen its CEO resign abruptly and as of July 2017, it seemed to struggle meeting financial projections.

Looking for leads, investment insights, or competitive intelligence?

CEO

Daniel P. Florin

CEO Title

Interim Chief Executive Officer & Director

Sector

Health Care

Industry

Medical Products and Equipment

HQ Location

Warsaw, IN

Years on Fortune 500 List

2

Employees

18,500

Profile provided by S&P Global.
Key Financials (Last Fiscal Year)
$ millions% change
Revenues ($M)$7,68428.1%
Profits ($M)$305.9108.1%
Assets ($M)$26,684
Total Stockholder Equity ($M)$9,668.9
Market Value — as of March 31, 2017 ($M)$24,571
Profit Ratios
Profit as % of Revenues4.0%
Profits as % of Assets1.1%
Profits as % of Stockholder Equity3.2%
Earnings Per Share (Last Fiscal Year)
Earnings Per Share ($)1.51
EPS % Change (from 2015)96.1%
EPS % Change (5 year annual rate)-17.8%
EPS % Change (10 year annual rate)-7.8%
Total Return
Total Return to Investors (2016)1.4%
Total Return to Investors (5 year, annualized)15.1%
Total Return to Investors (10 year, annualized)3.2%
STOCK QUOTE
()0.00 0.00 (0)
  • Previous Close:
  • Market Cap: NaNB
  • Next Earnings Date:
  • High:
  • Low:
  • 52 Week High:
  • 52 Week Low:
  • 52 Week Change %: 0.00
  • P/E Ratio: n/a
  • EPS:
  • Dividend Yield: n/a

News about Zimmer Biomet Holdings